NEWS

Damartex
news

Results for the 2022/2023 Financial Year

A Year Dedicated to Securing the Group’s Future. Launch of the New Strategic Plan BUSINESS Damartex ended the 2022/23 financial year with sales of €650.4 Mn, down on the previous year (-9.5% at actual exchange rates, -9.0% at like-for-like exchange rates), still impacted by the unfavourable macroeconomic environment and the contraction in consumption observed in […]

Read more
Finalizing Restructuring Operations and Implementing New Financing

Damartex today announces the completion of its restructuring operations with its legacy banking partners and the Despature family group, its reference shareholder1 . The injection of new liquidity and the restructuring of the Group’s debt were finalized with today’s completion: These transactions were carried out in accordance with the agreement signed by the Group, its […]

Read more
Damartex Reaches Agreement With Its Banking Partners and Reference Shareholder

Restructuring Existing Debt and Securing New Financing. Damartex announces the signature on 19 July 2023 of an agreement with its legacy banking partners and its reference shareholder on the restructuring of its current financial debt and the securing of new financing. Against a difficult macroeconomic backdrop of war in Ukraine, inflationary pressure and the energy […]

Read more
Sales for the 2022/2023 Financial Year

A Continued Momentum of Agility Against a Still Deteriorated Backdrop. Damartex ended the 2022/2023 financial year with sales of €650.4 Mn, down against the previous year (-9.5% at actual exchange rates, -9.0% at like-for-like exchange rates), still impacted by the unfavourable macroeconomic environment and the contraction in consumption observed in certain markets, particularly the UK. […]

Read more
Revenue for the First Nine Months of the2022/2023 Financial Year

A resilient and high-growth Health division, in an environment that remains difficult and uncertain. Damartex closed the third quarter of the 2022/2023 financial year with a turnover of € 153.9 Mn, down from the previous year (-11,1% at actual exchange rates, -9,8% at like-for-like exchange rates). With the notable exception of healthcare – a, essential […]

Read more
Turnover for the 2nd quarter of the 2022/2023 financial year

Agility and Strong Fundamentals in a Still Challenging Environment Damartex ended the first half of the 2022/2023 financial year with sales of €364.6 Mn, down on the previous year (-9.2% at actual exchange rates, -9.1% at like for like exchange rates). In a context marked by inflation and the decline in purchasing power, sales amounted […]

Read more
Extra-Financial Performance Statement

The Extra-Financial Performance Statement presents the strategy and CSR indicators of the Damartex Group. It is published every year, after an external audit. Damartex has formalised its CSR policy, Change Our World, around three pillars: planet, ethics and solidarity. Commitment to the planet We have measured the carbon footprint of the entire value chain (scope […]

Read more
Turnover of the 1st quarter of the 2022/2023 Financial Year

Group Agility in a Still Deteriorated Economic Environment  In the first quarter of the 2022/2023 Financial year, the Damartex Group’s revenues amounted to €135.4 Mn, down -13.7% at actual exchange rates compared with the 1st quarter of 2021/2022 (-13.8% at like for like exchange rates). Over this period, the Group recruited 302,000 new customers. This […]

Read more
Acquisition of Icelus Médical

Strengthening of Santéol in the Paris Region The Damartex group announces the acquisition of 100% of the shares of the ADS company by Santéol holding. This operation, like the previous ones, is part of the implementation of the Group’s transformation plan “Transform to Accelerate – TTA 2.0”. The ADS company, a home healthcare provider (so-called […]

Read more